DISCO Announces Fourth Quarter and Fiscal Year 2025 Financial Results Fourth Quarter 2025 Total Revenue of $41.2 Million, A Year over Year Increase of 11% AUSTIN, Texas - February 25, 2026 - CS Disco, Inc. ("DISCO") (NYSE: LAW) today announced financial results for its fourth quarter and fiscal year ended December 31, 2025. "DISCO continues to show what's possible as an innovator in legal technology as our AI solutions were significant growth drivers in the fourth quarter and a key part of strong full-year ...

Core Insights - DISCO has launched an all-inclusive platform for litigation, investigations, and regulatory responses, integrating eDiscovery, Cecilia AI, deposition management, and timelines into a single solution at a transparent price [1] - The new platform aims to address the inadequacies of one-off eDiscovery products by providing a seamless end-to-end solution for modern litigation [1] - A new pricing model has been introduced, featuring a single, transparent per GB price on processed data without ingest fees, facilitating clearer cost comparisons [1] Group 1: Product Features - The DISCO platform includes premier eDiscovery technology for instant access to critical data [1] - Cecilia AI offers advanced AI-powered legal tools to streamline and accelerate litigation processes [1] - Deposition management and timeline capabilities are now integrated into the platform, previously sold separately as Case Builder [1] Group 2: Strategic Direction - The company emphasizes the importance of integrated tools that address the full litigation lifecycle for complex matters [1] - DISCO's CEO highlighted the need for innovation in response to fast-evolving generative AI capabilities [1] - The platform will be showcased at Legalweek, indicating the company's commitment to demonstrating its advancements in legal technology [1]

New York, New York--(Newsfile Corp. - February 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Class A common stock of NuScale Power Corporation (NYSE: SMR) between May 13, 2025 and November 6, 2025, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2026.SO WHAT: If you purchased NuScale Class A common stock duri ...

New York, New York--(Newsfile Corp. - February 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025 and October 31, 2025, inclusive (the "Class Period"), of the important April 13, 2026 lead plaintiff deadline.SO WHAT: If you purchased uniQure ordinary shares during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ar ...

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Oracle Corporation (NYSE: ORCL) between June 12, 2025, and December 16, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 6, 2026. SO WHAT: If you purchased Oracle common stock during the Class Period you may be enti ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased BellRing Brands, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought BellRing securities between November 19, 2024, and August 4, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 23, 2026 [3]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in recovering hundreds of millions for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and securing over $438 million for investors in 2019 [4]. Group 3: Case Background - The lawsuit alleges that BellRing's sales growth was misrepresented as being driven by consumer demand, while in reality, it was due to key customers stockpiling inventory [5]. - The company downplayed competitive pressures, claiming a strong market position, but later admitted that demand was weakening due to competition [5].

New York, New York--(Newsfile Corp. - February 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CoreWeave, Inc. (NASDAQ: CRWV) between March 28, 2025 and December 15, 2025, both dates inclusive (the "Class Period"), of the important March 13, 2026 lead plaintiff deadline.SO WHAT: If you purchased CoreWeave securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ...

Group 1 - The Rosen Law Firm is reminding purchasers of American Depositary Shares (ADS) of Mereo BioPharma Group plc (NASDAQ: MREO) about the lead plaintiff deadline of April 6, 2026, for a class action lawsuit [1] - Investors who purchased Mereo ADSs during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting the Rosen Law Firm [3][7] Group 2 - The lawsuit alleges that Mereo BioPharma provided misleading information regarding the expected results of the Phase 3 Orbit and COSMIC studies for setrusumab in Osteogenesis Imperfecta (OI) [5] - Defendants are accused of making positive statements about setrusumab's efficacy while concealing adverse facts about the Phase 3 programs, which did not meet their primary endpoints [6] - The misleading statements led to investors purchasing Mereo's ADSs at inflated prices, resulting in damages when the true information became public [6]

New York, New York--(Newsfile Corp. - February 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BlackRock TCP Capital Corp. (NASDAQ: TCPC) between November 6, 2024, and January 23, 2026, inclusive (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline.SO WHAT: If you purchased BlackRock TCP securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingenc ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased PomDoctor Ltd. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The class action lawsuit pertains to securities purchased between October 9, 2025, and December 11, 2025, with a lead plaintiff deadline set for April 7, 2026 [1][2]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success and recognition in the field [3]. - The firm has achieved significant settlements, including over $438 million for investors in 2019, and has been consistently ranked among the top firms for securities class action settlements [3]. Group 3: Case Allegations - The lawsuit alleges that PomDoctor made false or misleading statements and failed to disclose critical information regarding a fraudulent stock promotion scheme and insider trading activities [4]. - Specific allegations include the use of social media misinformation, coordinated share dumping by insiders, and omissions of artificial trading activity that misled investors about the company's prospects [4].